| Patents for C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids (89,892) |
|---|
| 01/09/2001 | US6172208 Oligonucleotides modified with conjugate groups |
| 01/09/2001 | US6172201 Cellular receptor for HIV-1 Vpr essential for G2/M phase |
| 01/09/2001 | US6172048 Composition containing nucleic acids, preparation and uses |
| 01/09/2001 | US6172047 Therapy for nervous system tumors |
| 01/09/2001 | US6171860 Oligonucleotides which target untranslated regions and start codons to prevent transcription of a gene; for treatment of bone disorders, inflammation and cancer; antiinflammatory agents; anticarcinogenic agents; antitumor agents |
| 01/09/2001 | US6171806 Isolated peptide defined by SEQ ID NO: 17 and uses thereof |
| 01/09/2001 | US6171803 Drug screening for allergy treatments by engineering expression of alpha, beta, and gamma subunits of receptor in host cell, incubating with candidate inhibitor, and analyzing for cell expression or cell activation |
| 01/09/2001 | US6171797 Methods of making polymeric arrays |
| 01/09/2001 | US6171795 Nucleic acid ligands to CD40ligand |
| 01/09/2001 | US6171794 Comparing dissociation curve for the hybridization to a dissociation profile of the reference polynucleotide; to identify the fraction of sequences which are perfectly complementary to a probe |
| 01/09/2001 | US6171784 Process for typing of HCV isolates |
| 01/09/2001 | US6171781 NF-AT polypeptides and polynucleotides |
| 01/09/2001 | US6171598 GTP cyclohydrolase II (RIBA) |
| 01/09/2001 | US6171555 Reaction block docking station |
| 01/09/2001 | CA2017269C Fluorogenic benzoxazoles |
| 01/04/2001 | WO2001000876A1 Nanoparticles having oligonucleotides attached thereto and uses therefor |
| 01/04/2001 | WO2001000843A2 Corynebacterium glutamicum genes encoding metabolic pathway proteins |
| 01/04/2001 | WO2001000808A1 Antisense modulation of ship-2 expression |
| 01/04/2001 | WO2001000642A1 High affinity, low molecular weight displacers for oligonucleotide purification |
| 01/04/2001 | WO2000061069A3 Methods and compositions for use in the treatment of hyperlipidemia |
| 01/04/2001 | WO2000029420A9 Methods of making modified nucleosides |
| 01/04/2001 | CA2593287A1 Corynebacterium glutamicum genes encoding proteins involved in carbon metabolism and energy production |
| 01/04/2001 | CA2383865A1 Corynebacterium glutamicum genes encoding metabolic pathway proteins |
| 01/04/2001 | CA2377437A1 Antisense modulation of ship-2 expression |
| 01/03/2001 | EP1065250A1 New fluorescent cyanine labels containing a sulfamido linker arm |
| 01/03/2001 | EP1064402A1 Antisense modulation of lfa-3 |
| 01/03/2001 | EP1064396A1 A selective assay for determining the identity of live microorganisms in a mixed culture |
| 01/03/2001 | EP1064391A1 Antisense modulation of human mdm2 expression |
| 01/03/2001 | EP1064380A1 EXPRESSION OF THE $i(INSL4) GENE IN HUMAN EMBRYONIC BONE TISSUES AND APPLICATIONS |
| 01/03/2001 | EP1064359A2 Phenol oxidizing enzyme enzymes |
| 01/03/2001 | EP1064295A1 METHODS AND COMPOSITIONS FOR DIAGNOSING AND TREATING CHROMOSOME-18p RELATED DISORDERS |
| 01/03/2001 | EP1064292A1 Photoactivatable nucleic acid derivatives |
| 01/03/2001 | EP0910467B1 Electrochemical solid phase synthesis of polymers |
| 01/03/2001 | CN1060177C 3'-monophosphorylated oligonucleotides |
| 01/02/2001 | US6169194 High surface density covalent immobilization of oligonucleotide monolayers using a 1-(thiotrifluoroacetato)-11-(trichlorososilyl)-undecane linker |
| 01/02/2001 | US6169177 Processes for the synthesis of oligomeric compounds |
| 01/02/2001 | US6169176 Synthesizing oligonucleotides having a backbone of alkyl or alkoxy thiourea linkages; antisense and gene therapy agents with increased affinity and nuclease resistance |
| 01/02/2001 | US6169174 Dna coding for a protein of defined amino acid sequence which controls fiber formation; for improvements in textile, paper and food industries |
| 01/02/2001 | US6169170 Oligonucleotide N3′→N5′Phosphoramidate Duplexes |
| 01/02/2001 | US6169169 PNA probes for detection of Neisseria gonorrhoeae and Chlamydia trachomatis |
| 01/02/2001 | US6169079 An antisense oligonucleotides designed to hybridize to the mrna encoding intercellular adhesion molecule-1, endothelial leukocyte adhesion molecule-1, and vascular cell adhesion molecule-1, for treating inflammation |
| 01/02/2001 | US6168940 Protein having ethylenediamine-N,N′-disuccinic acid:ethylenediamine lyase acitivity and gene encoding the same |
| 01/02/2001 | US6168778 Vascular endothelial growth factor (VEGF) Nucleic Acid Ligand Complexes |
| 01/02/2001 | CA2095613C Substituted 1, 3-oxathiolanes and substituted 1, 3-dithiolanes with antiviral properties |
| 01/02/2001 | CA2035899C Chimeric anti-cea antibody |
| 12/28/2000 | WO2000078935A1 Mevalonate pathway genes |
| 12/28/2000 | WO2000078781A1 Detection of giardia |
| 12/28/2000 | WO2000040593A3 Target molecule attachment to surfaces |
| 12/27/2000 | EP1063293A2 Transforming growth factor alpha H1 |
| 12/27/2000 | EP1063292A2 DNA encoding human alpha 1 adrenergic receptors and uses thereof |
| 12/27/2000 | EP1063291A2 DNA encoding human alpha 1 adrenergic receptors and uses thereof |
| 12/27/2000 | EP1063286A1 Substrates for immobilizing and amplifying dna, dna-immobilized chips having dna immobilized on the substrates, and method for amplifying dna |
| 12/27/2000 | EP1062508A1 Assays for screening compounds which interact with cation channel proteins, mutant prokaryotic cation channel proteins, and uses thereof |
| 12/27/2000 | EP1062366A1 Detection of neoplasia by analysis of saliva |
| 12/27/2000 | EP1062360A1 Compositions and methods for enhanced synthesis of nucleic acid molecules |
| 12/27/2000 | EP1062346A1 Gene encoding labyrinthin, a marker for cancer |
| 12/27/2000 | EP1062226A1 High affinity nucleic acid ligands of complement system proteins |
| 12/27/2000 | EP1062224A1 Modified factor viii |
| 12/27/2000 | EP1061950A1 Live vaccine for human immunodeficiency virus |
| 12/27/2000 | EP0886638A4 Improved process for the synthesis of oligomeric compounds |
| 12/27/2000 | EP0716604A4 Thiol-derivatized nucleosides and oligonucleosides |
| 12/27/2000 | CN1278006A Human G protein coupled receptor protein isomer, and coding series thereof |
| 12/27/2000 | CN1278005A Human nucleolar chromosome protein and coding series thereof |
| 12/27/2000 | CN1278004A Novel human immune glubulin receptor subunit protein, and coding series thereof |
| 12/27/2000 | CN1278003A Human spermidine/spermine acetyl transferase protein isomer, and coding series thereof |
| 12/27/2000 | CN1278002A Human RNA binding protein and coding series thereof |
| 12/27/2000 | CN1278001A Human dehydrogenase subunit protein isomer and coding series thereof |
| 12/27/2000 | CN1278000A Human glucotranferring protein, and coding series thereof |
| 12/27/2000 | CN1277999A Human cell periodic protein isomer protein, and coding series thereof |
| 12/27/2000 | CN1277998A Human nitrile hydrolytic enzyme protein and coding series thereof |
| 12/27/2000 | CN1277997A Glycoprotein relating to human muscle nutrition and coding series therefor |
| 12/27/2000 | CN1277970A Novel polypeptide-human sarcoma protein 20, and polynucleotide for coding same |
| 12/26/2000 | US6166294 Nucleotide sequences which are expressed at preferential time during plant development for more efficient production of plant by-product |
| 12/26/2000 | US6166239 Useful during oligonucleotide synthesis to protect nucleobase amines as well as tethered amines used for attaching functional moieties to oligonucleotides. |
| 12/26/2000 | US6166199 Contacting purine with amino, hydrazine, hydroxylamine, thiol, semicarbazide, thiosemicarbazide, hydrazone, hydrazide, imidazole, tetrazole, triazole, pyrrolidine, piperidine, piperazine, morpholine, aldehyde, ketone, alcohol; antisense |
| 12/26/2000 | US6166198 Methods for oligonucleotide synthesis |
| 12/26/2000 | US6166197 Oligomeric compounds having pyrimidine nucleotide (S) with 2'and 5 substitutions |
| 12/26/2000 | US6166188 Nucleosides and oligonucleosides functionalized to include carbamate functionality; for the diagnosis of normal or disease states of cells, cellular components or organisms and treatment of diseases through modulation of dna, rna |
| 12/26/2000 | US6166185 Antibodies to human TIE-2 ligands |
| 12/26/2000 | US6166176 Cancer marker protein and peptides thereof |
| 12/26/2000 | US6165791 Nucleotide sequences which prevent the transcription of genes associated with an activator of transcription; for the treatment of cell proliferation defects; antiproliferative agents; anticarcinogenic agents |
| 12/26/2000 | US6165790 Antisense modulation of PI3 kinase p55 gamma expression |
| 12/26/2000 | US6165789 Antisense modulation of hnRNP A1 expression |
| 12/26/2000 | US6165788 Antisense modulation of Survivin expression |
| 12/26/2000 | US6165765 Heat resistant enzyme from bacillus; for more accurate sequence determination using chain terminating nucleotides |
| 12/26/2000 | US6165760 Amino acid sequence of polypeptide of the glutamyl transfer rna synthetase family; drug screening of bacteriostats and bactericides; vaccines; diagnosis of infections |
| 12/26/2000 | US6165729 Electrochemiluminescent reaction utilizing amine-derived reductant |
| 12/26/2000 | US6165727 Analyzing the dna sequence of angiotensinogen gene for a mutation which is in linkage disequilibrium with mutation m235t; presence indicates predisposition |
| 12/26/2000 | US6165717 Method of synthesizing diverse collections of oligomers |
| 12/26/2000 | US6165713 Composition and methods relating to DNA mismatch repair genes |
| 12/26/2000 | CA2203494C Energy transfer dyes with enhanced fluorescence |
| 12/26/2000 | CA2089119C Hydrated silica and purification of dna |
| 12/21/2000 | WO2000077258A1 Markers for prostate cancer |
| 12/21/2000 | WO2000076554A1 Ligand-conjugated oligomeric compounds |
| 12/21/2000 | WO2000050443A3 Secreted proteins and uses thereof |
| 12/21/2000 | WO2000050062A3 Methods and compositions for altering mucus secretion |
| 12/21/2000 | WO2000044491A3 Centrifuging apparatus and method for separation of liquid phases and organic synthesis |
| 12/21/2000 | WO2000027860A8 Polynucleotide crosslinking agents |
| 12/21/2000 | CA2378745A1 Ligand-conjugated oligomeric compounds |
| 12/21/2000 | CA2375228A1 Markers for prostate cancer |